These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 11229775

  • 1. Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties.
    Scozzafava A, Menabuoni L, Mincione F, Mincione G, Supuran CT.
    Bioorg Med Chem Lett; 2001 Feb 26; 11(4):575-82. PubMed ID: 11229775
    [Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase inhibitors. A general approach for the preparation of water-soluble sulfonamides incorporating polyamino-polycarboxylate tails and of their metal complexes possessing long-lasting, topical intraocular pressure-lowering properties.
    Scozzafava A, Menabuoni L, Mincione F, Supuran CT.
    J Med Chem; 2002 Mar 28; 45(7):1466-76. PubMed ID: 11906288
    [Abstract] [Full Text] [Related]

  • 3. Carbonic anhydrase inhibitors: synthesis of water-soluble, topically effective intraocular pressure lowering aromatic/heterocyclic sulfonamides containing 8-quinoline-sulfonyl moieties: is the tail more important than the ring?
    Borras J, Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT.
    Bioorg Med Chem; 1999 Nov 28; 7(11):2397-406. PubMed ID: 10632049
    [Abstract] [Full Text] [Related]

  • 4. Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?
    Scozzafava A, Menabuoni L, Mincione F, Briganti F, Mincione G, Supuran CT.
    J Med Chem; 1999 Jul 15; 42(14):2641-50. PubMed ID: 10411484
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.
    Scozzafava A, Briganti F, Mincione G, Menabuoni L, Mincione F, Supuran CT.
    J Med Chem; 1999 Sep 09; 42(18):3690-700. PubMed ID: 10479300
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Carbonic anhydrase inhibitors. Water-soluble, topically effective intraocular pressure lowering agents derived from isonicotinic acid and aromatic/heterocyclic sulfonamides: is the tail more important than the ring?
    Menabuoni L, Scozzafava A, Mincione F, Briganti F, Mincione G, Supuran CT.
    J Enzyme Inhib; 1999 Sep 09; 14(6):457-74. PubMed ID: 10536879
    [Abstract] [Full Text] [Related]

  • 9. Carbonic anhydrase inhibitors. Part 79. Synthesis of topically acting sulfonamides incorporating GABA moieties in their molecule, with long-lasting intraocular pressure-lowering properties.
    Mincione G, Menabuoni L, Briganti F, Mincione F, Scozzafava A, Supuran CT.
    Eur J Pharm Sci; 1999 Dec 09; 9(2):185-99. PubMed ID: 10620731
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Carbonic anhydrase inhibitors: synthesis and topical intraocular pressure lowering effects of fluorine-containing inhibitors devoid of enhanced reactivity.
    de Leval X, Ilies M, Casini A, Dogné JM, Scozzafava A, Masini E, Mincione F, Starnotti M, Supuran CT.
    J Med Chem; 2004 May 20; 47(11):2796-804. PubMed ID: 15139757
    [Abstract] [Full Text] [Related]

  • 12. Carbonic anhydrase inhibitors: synthesis and inhibition against isozymes I, II and IV of topically acting antiglaucoma sulfonamides incorporating cis-5-norbornene-endo-3-carboxy-2-carboxamido moieties.
    Casini A, Mincione F, Ilies MA, Menabuoni L, Scozzafava A, Supuran CT.
    J Enzyme Inhib; 2001 May 20; 16(2):113-23. PubMed ID: 11342280
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Carbonic anhydrase inhibitors: novel compounds containing S-NH moieties: sulfenamido-sulfonamides, sulfenimido-sulfonamides and their interaction with isozymes I, II and IV.
    Scozzafava A, Supuran CT.
    J Enzyme Inhib; 1998 Sep 20; 13(6):419-42. PubMed ID: 9825306
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Carbonic anhydrase inhibitors: 4-sulfamoyl-benzenecarboxamides and 4-chloro-3-sulfamoyl-benzenecarboxamides with strong topical antiglaucoma properties.
    Mincione F, Starnotti M, Menabuoni L, Scozzafava A, Casini A, Supuran CT.
    Bioorg Med Chem Lett; 2001 Jul 09; 11(13):1787-91. PubMed ID: 11425561
    [Abstract] [Full Text] [Related]

  • 20. Carbonic anhydrase inhibitors with strong topical antiglaucoma properties incorporating a 4-(2-aminopyrimidin-4-yl-amino)-benzenesulfonamide scaffold.
    Casini A, Mincione F, Vullo D, Menabuoni L, Scozzafava A, Supuran CT.
    J Enzyme Inhib Med Chem; 2002 Feb 09; 17(1):9-18. PubMed ID: 12365464
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.